SES AI Corporation Key Metrics

1 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$-0
Book Value Per Share
$1
Free Cash Flow Per Share
$-0
Cash Per Share
$0
Revenue Per Share
$0
OCF Per Share
$-0
Return on Equity
-29.6%
Return on Assets
-24.2%
Return on Invested Capital
-26.5%
Current Ratio
8.95
Quick Ratio
8.74
Asset Turnover
0.07
Days Sales Outstanding
83.13
Days Payables Outstanding
214.41
Days Inventory On Hand
194.08
Cash Conversion Cycle
62.80
R&D / Revenue
319.3%
SBC / Revenue
52.2%
Capex / Revenue
13.6%
Working Capital
$192M
Net Current Asset Value
$158M
Invested Capital
$215M
OCF / Net Income
0.80
FCF / Net Income
0.84
Accruals Ratio (Sloan)
-5.4%
Net Debt
$-29M
Net Debt / EBITDA
0.40
Interest Coverage
-8.85
Cash Coverage
-6.25
Capex Coverage
-20.42
Tangible Common Equity
$199M
TCE / Total Assets
72.9%
Goodwill / Total Assets
4.9%
NOPAT
$-65M
Cash ROIC
-24.8%
WC / Revenue
914.9%
Capex / D&A
0.28
Reinvestment Rate
5.3%
Total Payout Ratio
-2.2%
Asset Growth vs Revenue Growth
-946.7%
Stock Price (FY-end)
$2
Market Cap
$596M
P/S Ratio
28.36
P/B Ratio
2.77
P/TB Ratio
3.00
Enterprise Value
$567M
EV / Sales
27.00
FCF Yield
-10.3%
Shareholder Yield
-1.6%
Buyback Yield
0.3%
R&D Yield
11.3%
Capex Yield
0.5%
Shares Variation (YoY)
2.8%
Beta (5Y)
1.44
Cost of Equity
11.7%
Cost of Debt (after tax)
888.8%
52W High
$4
52W Low
$0
Trailing Return 1Y
-24.7%
F-Score (Piotroski)
3.00
Z-Score (Altman)
4.19

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Beat / Miss vs Estimate

Stock Price on Earnings Dates

SES AI Corporation — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes-0.20%0.00%0.20%
Foreign Rate Differential-0.10%-0.10%-0.80%0.90%-0.30%
Other Adjustments0.10%0.20%-0.60%-0.60%0.00%
R&D Tax Credits2.20%-2.00%-2.40%-2.70%-1.30%-3.60%
SBC (Nondeductible)0.00%-1.10%4.10%-0.80%-1.00%-2.10%
Valuation Allowance Change-21.70%-22.00%-33.30%-18.30%-16.50%-15.60%
Tax Law Change-6.20%
Effective Tax Rate-0.10%-0.10%-2.50%1.60%-0.20%-0.30%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)$7.0K$25.0K$1.3M−$853.0K$188.0K$231.0K
Income Taxes Paid (Cash)$222.0K$286.0K

SES AI Corporation — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Shenzhen Uz Energy Co Ltd

Total Consideration

$183.5M

Purchase-Price Allocation

Goodwill

$13.3M

Contingent Earn-Out

$83.3M